Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3,270 JPY | -1.65% |
|
-1.06% | +28.74% |
Jul. 02 | Ardelyx, Inc. Chooses Not to File for TDAPA to Preserve Patient Access to XPHOZAH | CI |
Jun. 26 | Novo Nordisk to Take $816.2 Million Impairment Loss After Stopping Clarion-CKD Trial | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+28.74% | 1.38B | |
-10.22% | 13.58B | |
+3.83% | 5.44B | |
+102.25% | 5.35B | |
+16.72% | 4.61B | |
+13.06% | 4.35B | |
-15.78% | 4.19B | |
+20.94% | 4.12B | |
+15.73% | 3.81B | |
-35.94% | 3.52B |
- Stock Market
- Equities
- 6407 Stock
- News CKD Corporation
- XORTX Submits a New Patent for the Treatment of Chronic Kidney Disease